NO941358L - Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav - Google Patents
Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling deravInfo
- Publication number
- NO941358L NO941358L NO941358A NO941358A NO941358L NO 941358 L NO941358 L NO 941358L NO 941358 A NO941358 A NO 941358A NO 941358 A NO941358 A NO 941358A NO 941358 L NO941358 L NO 941358L
- Authority
- NO
- Norway
- Prior art keywords
- suspension
- aqueous pharmaceutical
- preparation
- carboxymethyl cellulose
- pharmaceutical suspension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Det er beskrevet et vandig farmasøytisk suspensjons- preparat Inneholdende suspendert acetamlnofen og minst en ytterligere farmasøytisk aktiv bestanddel, et suspensjonssystem Inneholdende xantan-gumml, en blanding av mlkrokrystalllnsk cellulose og natrlum- karboksymetylcellulose og et hjelpesuspensjonsmlddel valgt fra gruppen bestående av hydroksyetylcellulose og et farmasøytisk akseptabelt salt av karboksymetyl- cellulose, en effektiv mengde av en smaksmaskerende sammensetning; og vann, såvel som en fremgangsmåte for fremstilling av silke vandlge, farmasøytiske suspen- sjoner.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4870193A | 1993-04-16 | 1993-04-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO941358D0 NO941358D0 (no) | 1994-04-15 |
NO941358L true NO941358L (no) | 1994-10-17 |
Family
ID=21955969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO941358A NO941358L (no) | 1993-04-16 | 1994-04-15 | Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav |
Country Status (5)
Country | Link |
---|---|
US (1) | US5658919A (no) |
EP (1) | EP0620001A1 (no) |
CA (1) | CA2121435C (no) |
FI (1) | FI941777A (no) |
NO (1) | NO941358L (no) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5534552A (en) * | 1994-03-02 | 1996-07-09 | Warner-Lambert Company | Clear non-alcoholic sinus and allergy medication |
BR9505962A (pt) * | 1994-12-21 | 1997-12-23 | Johnson & Johnson | Suspensão farmacêutica aquosa e processo para sua preparação |
US5563177A (en) * | 1995-01-30 | 1996-10-08 | American Home Products Corporation | Taste masking guaifenesin containing liquids |
NZ272574A (en) * | 1995-07-14 | 1999-02-25 | Lilly Eli & Co Nz Ltd | Aqueous base suspension concentrate containing at least one ionophore antibiotic and wetting agent and/or a surfactant and xanthan gum optionally with a suspension agent, an antifreeze agent and an antifoaming agent; drench for veterinary treatment |
ATE264667T1 (de) * | 1995-07-14 | 2004-05-15 | Elli Lilly & Co Nz Ltd | Formulierungen mit monensin |
AU774516C (en) * | 1995-07-14 | 2005-12-22 | Eli Lilly & Co (Nz) Limited | Ionophore antibiotic formulations |
NZ280384A (en) | 1995-11-02 | 1997-01-29 | Lilly Eli & Co Nz Ltd | Animal feed supplement comprising a wettable powder composition of an ionophore antibiotic |
FR2751875B1 (fr) * | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
US6132758A (en) | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
USH2044H1 (en) | 1998-11-02 | 2002-09-03 | Mcneil-Ppc, Inc. | Container with retaining member |
AU2002220248A1 (en) * | 2000-11-06 | 2002-05-15 | Andrx Pharmaceuticals, Inc. | Once a day antihistamine and decongestant formulation |
BR0207930A (pt) * | 2001-03-05 | 2004-03-02 | Ortho Mcneil Pharm Inc | Composições farmacêuticas lìquidas com sabor mascarado |
JP2004538309A (ja) * | 2001-07-31 | 2004-12-24 | ワイエス | 不快な味覚をマスキングするためのスクラロース調合物 |
US7101572B2 (en) * | 2001-12-07 | 2006-09-05 | Unilab Pharmatech, Ltd. | Taste masked aqueous liquid pharmaceutical composition |
ME00483B (me) * | 2001-12-18 | 2011-10-10 | Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A | Parenteralni sastav paracetamola |
US6602490B1 (en) * | 2002-03-04 | 2003-08-05 | Richard A. Cloonan | Dental cleaning formulation and manufacturing process |
US7049435B2 (en) | 2002-03-08 | 2006-05-23 | Tate & Lyle Public Limited Company | Extractive methods for purifying sucralose |
US6998480B2 (en) | 2002-03-08 | 2006-02-14 | Tate & Lyle Public Limited Company | Process for improving sucralose purity and yield |
US7300670B2 (en) * | 2002-04-03 | 2007-11-27 | Unilab Pharmatech, Ltd. | Oral suspension formulation |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US20040101563A1 (en) * | 2002-07-18 | 2004-05-27 | Kundu Subhas C. | Storage stable antihistaminic syrup formulations |
US20040138200A1 (en) * | 2002-10-04 | 2004-07-15 | Michael Hawley | Pharmaceutical compositions for treatment of Parkinson's disease |
US8092831B2 (en) * | 2002-11-08 | 2012-01-10 | Andrx Pharmaceuticals, Llc | Antihistamine and decongestant system |
US20040170686A1 (en) * | 2003-01-31 | 2004-09-02 | Fredrickson Jennifer K. | Suspension vehicle for coated drug particles |
US20040191326A1 (en) * | 2003-03-31 | 2004-09-30 | Reo Joseph P. | Taste-masking vehicle for coated oxazolidinone particles |
US20050069590A1 (en) | 2003-09-30 | 2005-03-31 | Buehler Gail K. | Stable suspensions for medicinal dosages |
US20050095299A1 (en) * | 2003-10-30 | 2005-05-05 | Wynn David W. | Controlled release analgesic suspensions |
US20050095300A1 (en) * | 2003-10-30 | 2005-05-05 | Wynn David W. | Controlled release analgesic suspensions |
US20050266031A1 (en) * | 2004-05-25 | 2005-12-01 | Jay Dickerson | Pharmaceutical suspension composition |
US20060062811A1 (en) * | 2004-09-21 | 2006-03-23 | Szymczak Christopher E | Medicinal cooling emulsions |
US20060093629A1 (en) | 2004-10-29 | 2006-05-04 | Buehler Gail K | Dye-free pharmaceutical suspensions and related methods |
US20060093631A1 (en) * | 2004-10-29 | 2006-05-04 | Buehler Gail K | Dye-free pharmaceutical suspensions and related methods |
US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
DK2377557T3 (en) | 2004-11-24 | 2017-02-06 | Meda Pharmaceuticals Inc | Compositions comprising azelastine and methods for its use |
US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
US20070026026A1 (en) * | 2005-08-01 | 2007-02-01 | David Delmarre | Oral liquid losartan compositions |
GB2438287A (en) * | 2006-05-19 | 2007-11-21 | Norbrook Lab Ltd | Stable aqueous suspension |
US20080014275A1 (en) * | 2006-07-13 | 2008-01-17 | Buehler Gail K | Pharmaceutical suspensions and related methods |
MX2009010407A (es) | 2007-03-28 | 2009-12-01 | Apotex Technologies Inc | Derivados fluorados de deferiprona. |
US9149429B2 (en) * | 2007-11-21 | 2015-10-06 | The Procter & Gamble Company | Preparations, methods and kits useful for the treatment of cough |
AR070082A1 (es) * | 2008-01-04 | 2010-03-10 | Tate & Lyle Technology Ltd | Metodo para la produccion de sucralosa |
US8362083B2 (en) * | 2008-01-15 | 2013-01-29 | C.B. Fleet Company Inc. | Taste-masked docusate compositions |
CN101977664B (zh) * | 2008-03-20 | 2014-02-26 | 塔特和莱利技术有限公司 | 从叔酰胺溶剂中去除酸 |
US8436157B2 (en) * | 2008-03-26 | 2013-05-07 | Tate & Lyle Technology Limited | Method for the production of sucralose |
AR071134A1 (es) * | 2008-04-03 | 2010-05-26 | Tate & Lyle Technology Ltd | Cristalizacion de sucralosa a partir de chorros que contienen sucralosa |
US8497367B2 (en) * | 2008-04-03 | 2013-07-30 | Tate & Lyle Technology Limited | Sucralose purification process |
KR20100127875A (ko) * | 2008-04-03 | 2010-12-06 | 테이트 앤드 라일 테크놀러지 리미티드 | 수크랄로오스 추출 효율에 대한 탄수화물 농도의 효과 |
US20090259036A1 (en) * | 2008-04-03 | 2009-10-15 | Tate & Lyle Technology Limited | Extraction of less polar impurities from sucralose containing aqueous feed streams |
UA102254C2 (ru) * | 2008-04-25 | 2013-06-25 | Апотекс Технолоджис Инк. | Жидкий состав для деферипрона с приятным вкусом |
GB2469158B (en) | 2009-03-31 | 2011-09-28 | Peter J Seaberg | Base-assisted formation of tin-sucrose adducts |
EP2448922B1 (en) | 2009-07-03 | 2014-08-20 | Apotex Technologies Inc. | Fluorinated derivatives of 3-hydroxypyridin-4-ones |
GB2474311B (en) * | 2009-10-12 | 2012-10-17 | Tate & Lyle Technology Ltd | Low temperature, single solvent process for the production of sucrose-6-ester |
GB2474310B (en) | 2009-10-12 | 2012-02-29 | Tate & Lyle Technology Ltd | Process for the production of sucrose-6-ester |
CA2831566A1 (en) * | 2011-03-31 | 2012-10-04 | Jitendra Krishan Somani | Menthol liquids composition |
GB201110520D0 (en) | 2011-05-10 | 2011-08-03 | Tate & Lyle Technology Ltd | Extraction of carboxylic acids with tin compounds |
EP3061501A1 (en) | 2015-02-27 | 2016-08-31 | Rottapharm Ltd. | Composition for the treatment of acne |
EP3117825A1 (en) | 2015-07-16 | 2017-01-18 | Rottapharm S.p.A. | Oral formulation comprising berberine and morus alba extract |
CN109906079B (zh) * | 2016-06-16 | 2022-09-30 | 库蒂斯制药公司 | 用于质子泵抑制剂混悬剂的组合物和方法 |
US11234897B2 (en) | 2017-03-27 | 2022-02-01 | DXM Pharmaceutical, Inc. | Packaged multi-dose liquid dextromethorphan hydrobromide formulation |
EP3691748A4 (en) * | 2017-10-03 | 2021-07-07 | Nevakar, Inc | ACETAMINOPHEN-PREGABALIN COMBINATIONS AND METHODS OF TREATMENT OF PAIN |
GR1009462B (el) * | 2017-10-05 | 2019-02-15 | Laboserve Φαρμακευτικη Βιομηχανια Α.Ε. | Ποσιμο φαρμακευτικο διαλυμα με συγκαλυμμενη γευση |
BR112021003544A2 (pt) | 2018-08-28 | 2021-05-18 | Gsk Consumer Healthcare Sarl | suspensões líquidas de paracetamol |
KR20200053746A (ko) | 2018-11-09 | 2020-05-19 | (주)아모레퍼시픽 | 졸-겔 조성물 |
US11633478B2 (en) | 2019-07-16 | 2023-04-25 | Azurity Pharmaceuticals, Inc. | Compositions and kits for Omeprazole suspension |
US10751333B1 (en) | 2019-07-16 | 2020-08-25 | Cutispharma, Inc. | Compositions and kits for omeprazole suspension |
CN112274483A (zh) * | 2020-10-28 | 2021-01-29 | 河北冀衡药业股份有限公司 | 一种对乙酰氨基酚混悬滴剂及其制备方法 |
CN112587483A (zh) * | 2020-12-16 | 2021-04-02 | 上海应用技术大学 | 一种具有掩味效果的小儿复方感冒干混悬剂及其制备方法和应用 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3539365A (en) * | 1967-02-13 | 1970-11-10 | Fmc Corp | Dispersing and stabilizing agent comprising beta-1,4 glucan and cmc and method for its preparation |
US4145440A (en) * | 1977-08-18 | 1979-03-20 | The Upjohn Company | Liquid suspension of an aluminum salt of ibuprofen |
US4361580A (en) * | 1980-06-20 | 1982-11-30 | The Upjohn Manufacturing Company | Aluminum ibuprofen pharmaceutical suspensions |
US4327076A (en) * | 1980-11-17 | 1982-04-27 | Life Savers, Inc. | Compressed chewable antacid tablet and method for forming same |
US4923981A (en) * | 1982-09-03 | 1990-05-08 | Sbp, Inc. | Use of parenchymal cell cellulose to improve comestibles |
US4427681A (en) * | 1982-09-16 | 1984-01-24 | Richardson-Vicks, Inc. | Thixotropic compositions easily convertible to pourable liquids |
US5173305A (en) * | 1985-03-06 | 1992-12-22 | Grimberg Georges Serge | Composition for protection of oesogastroduodenal mucous membrane |
IT1183574B (it) * | 1985-05-08 | 1987-10-22 | Eurand Spa | Metodo per ottenere una sospensione estemporanea omogenea di microcapsule |
US4857324A (en) * | 1985-10-08 | 1989-08-15 | American Home Products Corporation (Del.) | Exogenously acidified antacid compositions having cytoprotective properties |
US4716033A (en) * | 1986-03-27 | 1987-12-29 | Warner-Lambert Company | Medicament adsorbates with surfactant and their preparation |
US4711774A (en) * | 1986-03-27 | 1987-12-08 | Warner-Lambert Company | Medicament adsorbates with complex magnesium aluminum silicate and their preparation |
US4717565A (en) * | 1986-03-27 | 1988-01-05 | Warner-Lambert Company | Process for the preparation of medicament adsorbates |
US4761274A (en) * | 1986-03-27 | 1988-08-02 | Warner-Lambert Company | Medicament adsorbates of analgesics with complex magnesium aluminum silicate and their preparation |
GB8618847D0 (en) * | 1986-08-01 | 1986-09-10 | Smith Kline French Lab | Pharmaceutical formulations |
US4895723A (en) * | 1986-09-08 | 1990-01-23 | Amer And Company | Cholestyramine compositions and method for preparation thereof |
CA1276022C (en) * | 1986-11-21 | 1990-11-06 | Arthur P. G. Wright | Essentially pure acidic amine ligand aluminum complexes and their preparation |
CA1287627C (en) * | 1986-11-21 | 1991-08-13 | Arthur P.G. Wright | Essentially pure polyalcohol aluminum complexes and their preparation |
US4772724A (en) * | 1986-12-02 | 1988-09-20 | Warner-Lambert Canada Inc. | Essentially pure acid hydroxyl ligand aluminum complexes and their preparation |
US4882324A (en) * | 1986-11-21 | 1989-11-21 | Wright Arthur P G | Essentially pure acid hydroxyl ligand aluminum complexes and their preparation |
GB8628359D0 (en) * | 1986-11-27 | 1986-12-31 | Zyma Sa | Galenical formulation |
US4788220A (en) * | 1987-07-08 | 1988-11-29 | American Home Products Corporation (Del.) | Pediatric ibuprofen compositions |
IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it |
US4975465A (en) * | 1989-03-28 | 1990-12-04 | American Home Products Corporation | Orally administrable ibuprofen compositions |
NZ234143A (en) * | 1989-06-28 | 1991-10-25 | Mcneil Ppc Inc | Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents |
US5112604A (en) * | 1989-09-01 | 1992-05-12 | Riker Laboratories, Inc. | Oral suspension formulation |
US5013557A (en) * | 1989-10-03 | 1991-05-07 | Warner-Lambert Company | Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same |
US5024997A (en) * | 1990-06-22 | 1991-06-18 | American Home Products Corporation | Palatable ibuprofen solutions |
US5196436A (en) * | 1990-10-31 | 1993-03-23 | The Procter & Gamble Company | Dextromethorphan antitussive compositions |
US5107842A (en) * | 1991-02-22 | 1992-04-28 | Molecular Biosystems, Inc. | Method of ultrasound imaging of the gastrointestinal tract |
US5205290A (en) * | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
US5167964A (en) * | 1992-02-14 | 1992-12-01 | Warner-Lambert Company | Semi-enteric drug delivery systems and methods for preparing same |
-
1994
- 1994-04-15 EP EP94302700A patent/EP0620001A1/en not_active Withdrawn
- 1994-04-15 FI FI941777A patent/FI941777A/fi not_active Application Discontinuation
- 1994-04-15 CA CA002121435A patent/CA2121435C/en not_active Expired - Lifetime
- 1994-04-15 NO NO941358A patent/NO941358L/no unknown
-
1996
- 1996-09-09 US US08/711,140 patent/US5658919A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2121435C (en) | 2002-01-22 |
FI941777A0 (fi) | 1994-04-15 |
NO941358D0 (no) | 1994-04-15 |
US5658919A (en) | 1997-08-19 |
FI941777A (fi) | 1994-10-17 |
EP0620001A1 (en) | 1994-10-19 |
CA2121435A1 (en) | 1994-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO941358L (no) | Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav | |
AR002976A1 (es) | Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas | |
DK0865281T3 (da) | Naphthylsubstituerede benzimidazolderivater som antikoagulerende midler | |
ES8802228A1 (es) | Un procedimiento para la preparacion de nuevas piranopiridinas | |
ATE100708T1 (de) | Unbeschichtete pharmazeutische reaktionstablette. | |
DK0894084T3 (da) | Kanelsyrederivater og deres anvendelse som integrinantagonister | |
NO863823L (no) | 1,5-benzothiazepinderivater som er anvendelige som utgangsmaterialer ved fremstilling av nye, terapeutisk aktive 8-klor-1,5-benzothiazepinderivater, og fremgangsmaate ved deres fremstilling. | |
IE832436L (en) | Novel chromans and chromenes | |
AU7484887A (en) | Method for inhibiting aging | |
ES8800153A1 (es) | Procedimiento para la obtencion de formulaciones medicionales solidas de nitrendipina cristalina. | |
DK157785A (da) | 1,5-benzothiazepinderivater og fremgangsmaade til deres fremstilling | |
GR1003658B (el) | Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου | |
NO20010089L (no) | Farmasöytisk levotyroksinpreparat | |
NO932054L (no) | Fremgangsmaate for fremstilling av en fast enhetsdoseringsform med regulert frigjoeringseffekt | |
HUT64518A (en) | Process for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents | |
AU582235B2 (en) | Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs | |
FI872255A (fi) | Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi | |
ES8707217A1 (es) | Un procedimiento para preparar un derivado de 1,5-benzotiazepina | |
NO20013601L (no) | Nye morfolinobenzamidsalter | |
ATE85047T1 (de) | Indol-derivate. | |
CA2002552A1 (en) | Pharmaceutical aqueous solution for ophthalmic use comprising a water solube pharmaceutically acceptable acid addition salt of ibopamine | |
ES8405781A1 (es) | Metodo de obtencion de derivados n-metilcarbamaticos utiles para insecticidas. | |
TR200102993T2 (tr) | 5-Kloro-2- metoksi-n-(2-(4-metoksi-3-metil aminotio karbonilamino slfonilfenil)etil)benzamid sodyum tuzunun kristalallin biimleri. | |
GB1468632A (en) | Imidazolyl compounds and process for their manufacture | |
MY101746A (en) | 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof. |